According to IMARC Group’s latest report,titled “MedicalSimulation Market Report: GlobalIndustry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global medical simulation marketexhibited strong growth during 2015-2020. Medicalsimulation refers to the virtual duplication of healthcare activities for the trainingof nurses, physicians, surgeons and other practitioners. It is an artificial representation of the real-world processes to facilitate experiential learning of various gynecological, cardiac, surgical and arthroscopic procedures. The medical simulation aids in improving patient safety and enhancing the psychomotor, clinical decision-making and crisis resource management skills of the healthcare providers. As a result, it is widely used across military organizations, hospitals, research facilities, academic institutes and ambulatory care centers.
We areregularly tracking the direct effect of COVID-19 on the market, along with theindirect influence of associated industries. These observations will be integrated into the report.
The global medical simulation market is primarilybeing driven by significant growth in the healthcare industry. Medicalsimulators are widely being adopted due to the increasing concern over patient safety and providing adequate procedural training to professionals. Moreover, various technological advancements, such as the integration of simulators with artificial intelligence (AI) and augmented reality (AR) solutions, are providing a thrust to the market growth. These technologies aid in monitoring the behavior of the clinicians and their interaction with the laboratory, medical systems and clinical equipment. Other factors, including the increasing requirement for medical simulation for minimally invasive (MI) procedures, along with the widespread adoption of laparoscopic simulation systems for effective cancer treatment, are creating a positive outlook for the market. Looking forward, IMARC Group expects the market to grow at a CAGR of around 12% during 2021-2026.
· Cardionics Inc.
· 3B Scientific GmbH
· Gaumard ScientificCompany Inc.
· Kyoto Kagaku Co.Ltd
· Laerdal Medical
· OperativeExperience Inc.
· Simbionix USACorporation
· 3D Systems
· Simulab Corporation
· Surgical ScienceSweden AB
· Synaptive MedicalInc.
· SynBone AG
· VirtaMed AG.
Breakup byProduct and Services:
· Model-based Simulation
· Surgical Simulation
· Ultrasound Simulation
· Web-based Simulation
· Simulation Training Services
· Low Fidelity
· Medium Fidelity
· High Fidelity
Breakup by EndUser:
· Hospitals and Clinics
· Academic Institutions and Research Centers
· Military Organizations
Breakup by Region:
· AsiaPacific (China, Japan, India, Australia, Indonesia, Korea, Others)
· LatinAmerica (Brazil, Mexico, Others)
· MiddleEast and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)
Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Market Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
- If youneed specific information that is not currently within the scope of the report,we will provide it to you as a part of the customization.
IMARC Group isa leading market research company that offers management strategy and marketresearch worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’sinformation products include major market, scientific, economic andtechnological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Tel No:(D) +91 120 433 0800
Americas: - +1 631 791 1145 | Africa and Europe: -+44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800